参考文献:
Zelic R, Garmo H, Zugna D, Stattin P, Richiardi L, Akre O, Pettersson A. Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study.Eur Urol 2019 Oct 9. pii: S0302-2838(19)30755-9.
Spratt DE, Schaeffer EM. Transcriptomic Heterogeneity of Favorable-risk Prostate Cancer: Time To Move Past Cancer of the Prostate Risk Assessment (CAPRA) to Clinical-genomic Risk.Eur Urol. 2018 Oct;74(4):453-454
|